Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 9 7 2022
medline: 11 1 2023
entrez: 8 7 2022
Statut: ppublish

Résumé

Spectral-domain optical coherence tomography (SD-OCT) was used to evaluate, in patients with multiple sclerosis without a history of optic neuritis (MSNON), the proportion of the different macular ganglion cell-inner plexiform layer complex (mGCIP) defect patterns. The results were compared with those of healthy controls (HCs). In this cross-sectional case-control study, 34 eyes of 34 individuals, 17 with MSNON and 17 HCs, were evaluated. All participants underwent mGCIP thickness measurement using SD-OCT (Zeiss Cirrus HD-OCT 4000, macular cube protocol). The mGCIP defect patterns were classified in nine types (minimal, inner, outer, diffuse mild, diffuse severe inferior confined, inferior dominant, superior confined, and superior dominant), according to the shape derived by the deviation map of the instrument, and the proportion of each type was assessed. A mGCIP defect pattern was detected in 70.5% of MSNON eyes, with an inner type as the most frequent pattern (47%), followed by the outer type (11.7%) and the inferior confined type (11.7%). No defect was found in Hcs. A significant thinning of the mGCIP with the frequent presence of an inner defect was seen in MSNON patients. The presence of this defect may serve as a biomarker of subclinical optic nerve involvement in MS patients.

Identifiants

pubmed: 35799453
doi: 10.1177/11206721221112803
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

546-555

Auteurs

Valeria Albano (V)

Department of Neurosciences, Institute of Ophthalmology, University of Bari, Bari, Italy.

Rosanna Dammacco (R)

Department of Neurosciences, Institute of Ophthalmology, University of Bari, Bari, Italy.

Alessia Manni (A)

Department of Neurosciences, Institute of Neurology, University of Bari, Bari, Italy.

Dario Sisto (D)

Department of Neurosciences, Institute of Ophthalmology, University of Bari, Bari, Italy.

Antonio Iaffaldano (A)

Department of Neurosciences, Institute of Neurology, University of Bari, Bari, Italy.

Alberto Mavilio (A)

27287Local Health Authority Brindisi, Social Health District, Brindisi, Italy.

Giovanni Alessio (G)

Department of Neurosciences, Institute of Ophthalmology, University of Bari, Bari, Italy.

Maria Trojano (M)

Department of Neurosciences, Institute of Neurology, University of Bari, Bari, Italy.

Damiano Paolicelli (D)

Department of Neurosciences, Institute of Ophthalmology, University of Bari, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH